Quimioterapia de elección tras hormonoterapia en cáncer de mama metastásico - page 16

Nab-Paclitaxel in MBC: Defining the best Rx regimen
Arpino et al Crti Rev Oncol Hematol 2016
Aggressive
Indolent
Fit
Unfit
1...,6,7,8,9,10,11,12,13,14,15 17,18,19,20,21,22,23,24,25,26,...36
Powered by FlippingBook